147 related articles for article (PubMed ID: 33450487)
1. Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.
Paterek A; Sochanowicz B; Oknińska M; Śmigielski W; Kruszewski M; Mackiewicz U; Mączewski M; Leszek P
Biomed Pharmacother; 2021 Apr; 136():111250. PubMed ID: 33450487
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.
Wang J; Yang YM; Li Y; Zhu J; Lian H; Shao XH; Zhang H; Fu YC; Zhang LF
J Cardiovasc Electrophysiol; 2019 Feb; 30(2):242-252. PubMed ID: 30302853
[TBL] [Abstract][Full Text] [Related]
4. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.
Suffredini S; Stillitano F; Comini L; Bouly M; Brogioni S; Ceconi C; Ferrari R; Mugelli A; Cerbai E
Br J Pharmacol; 2012 Mar; 165(5):1457-66. PubMed ID: 21838751
[TBL] [Abstract][Full Text] [Related]
6. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report.
Núñez L; Crespo-Leiro MG; Marrón-Liñares GM; Suarez-Fuentetaja N; Barge-Caballero E; Paniagua-Martín MJ; Marzoa-Rivas R; Grille-Cancela Z; Muñiz-García J; Vazquez-Rodriguez JM; Hermida-Prieto M
Cardiol J; 2016; 23(5):573-582. PubMed ID: 27439367
[TBL] [Abstract][Full Text] [Related]
7. Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.
Chobanyan-Jürgens K; Heusser K; Duncker D; Veltmann C; May M; Mehling H; Luft FC; Schröder C; Jordan J; Tank J
Sci Rep; 2018 May; 8(1):7748. PubMed ID: 29773827
[TBL] [Abstract][Full Text] [Related]
8. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
Fang Y; Debunne M; Vercauteren M; Brakenhielm E; Richard V; Lallemand F; Henry JP; Mulder P; Thuillez C
J Cardiovasc Pharmacol; 2012 Mar; 59(3):260-7. PubMed ID: 22075752
[TBL] [Abstract][Full Text] [Related]
9. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model.
Zicha S; Fernández-Velasco M; Lonardo G; L'Heureux N; Nattel S
Cardiovasc Res; 2005 Jun; 66(3):472-81. PubMed ID: 15914112
[TBL] [Abstract][Full Text] [Related]
10. Ivabradine restores tonic cardiovascular autonomic control and reduces tachycardia, hypertension and left ventricular inflammation in post-weaning protein malnourished rats.
Guedes MR; de Noronha SISR; Chírico MTT; da Costa GDC; de Freitas Castro T; de Brito RCF; Vieira LG; Reis TO; Ribeiro MC; Reis AB; Carneiro CM; Bezerra FS; Montano N; da Silva VJD; de Menezes RCA; Chianca-Jr DA; Silva FCDS
Life Sci; 2024 Jun; 346():122636. PubMed ID: 38614307
[TBL] [Abstract][Full Text] [Related]
11. Preclinical results with I(f) current inhibition by ivabradine.
Berdeaux A
Drugs; 2007; 67 Suppl 2():25-33. PubMed ID: 17999561
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
Sarre A; Pedretti S; Gardier S; Raddatz E
Pharmacol Res; 2010 Jan; 61(1):85-91. PubMed ID: 19818405
[TBL] [Abstract][Full Text] [Related]
13. Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling.
Ceconi C; Comini L; Suffredini S; Stillitano F; Bouly M; Cerbai E; Mugelli A; Ferrari R
Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H366-73. PubMed ID: 20952661
[TBL] [Abstract][Full Text] [Related]
14. LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model.
Chang PC; Lin SF; Chu Y; Wo HT; Lee HL; Huang YC; Wen MS; Chou CC
Cardiovasc Ther; 2019; 2019():6032631. PubMed ID: 31772612
[TBL] [Abstract][Full Text] [Related]
15. Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.
Kim BH; Cho KI; Kim SM; Kim N; Han J; Kim JY; Kim IJ
Heart Vessels; 2013 Jul; 28(4):524-35. PubMed ID: 23142972
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat.
Mackiewicz U; Gerges JY; Chu S; Duda M; Dobrzynski H; Lewartowski B; Mączewski M
J Cell Physiol; 2014 Jun; 229(6):813-23. PubMed ID: 24590965
[TBL] [Abstract][Full Text] [Related]
17. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
Maczewski M; Mackiewicz U
Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
[TBL] [Abstract][Full Text] [Related]
18. Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension.
Gomez O; Okumura K; Honjo O; Sun M; Ishii R; Bijnens B; Friedberg MK
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H542-H551. PubMed ID: 29146614
[TBL] [Abstract][Full Text] [Related]
19. Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol-induced myocardial injury.
Simko F; Baka T; Repova K; Aziriova S; Krajcirovicova K; Paulis L; Adamcova M
Fundam Clin Pharmacol; 2021 Aug; 35(4):744-748. PubMed ID: 33098700
[TBL] [Abstract][Full Text] [Related]
20. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure.
Dedkov EI; Bogatyryov Y; McCooey DS; Christensen LP; Weiss RM; Tomanek RJ
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
